Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Monte Rosa Therapeutics, Inc. (GLUE) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Monte Rosa Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1826457.
Total stock buying since 2021: $14,458,385.
Total stock sales since 2021: $12,317,725.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 10,000 | $58,380 | 2,062 | $9,173 | 0 | $0 |
| 2024 | 0 | $0 | 1,860,491 | $12,308,552 | 0 | $0 |
| 2021 | 757,895 | $14,400,005 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 2,062 | $9,173 | 0 | $0 |
| 2025-03 | 10,000 | $58,380 | 0 | $0 | 0 | $0 |
| 2024-10 | 0 | $0 | 157,895 | $1,497,062 | 0 | $0 |
| 2024-09 | 0 | $0 | 1,699,779 | $10,800,448 | 0 | $0 |
| 2024-07 | 0 | $0 | 1,610 | $6,166 | 0 | $0 |
| 2024-06 | 0 | $0 | 1,207 | $4,876 | 0 | $0 |
| 2021-06 | 757,895 | $14,400,005 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-03 | Dunn Edmund (Principal Accounting Officer) | Sale | 2,062 | 4.45 | 9,173 |
| 2025-03-24 | Leo Chandra P. | Buy | 10,000 | 5.84 | 58,380 |
| 2024-10-29 | Versant Vantage I Gp-gp, Llc | Sale | 67,905 | 9.25 | 627,849 |
| 2024-10-28 | Versant Vantage I Gp-gp, Llc | Sale | 89,990 | 9.66 | 869,213 |
| 2024-09-20 | Versant Vantage I Gp-gp, Llc | Sale | 1,132,566 | 6.53 | 7,395,655 |
| 2024-09-13 | Versant Vantage I Gp-gp, Llc | Sale | 9,269 | 6.16 | 57,097 |
| 2024-09-12 | Versant Vantage I Gp-gp, Llc | Sale | 16,047 | 6.00 | 96,314 |
| 2024-09-11 | Versant Vantage I Gp-gp, Llc | Sale | 541,897 | 6.00 | 3,251,382 |
| 2024-07-05 | Dunn Edmund (Principal Accounting Officer) | Sale | 1,610 | 3.83 | 6,166 |
| 2024-06-03 | Dunn Edmund (Principal Accounting Officer) | Sale | 1,207 | 4.04 | 4,876 |
| 2021-06-28 | Versant Vantage I Gp-gp, Llc (10% Owner) | Buy | 157,895 | 19.00 | 3,000,005 |
| 2021-06-28 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 600,000 | 19.00 | 11,400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of GLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Monte Rosa Therapeutics, Inc. (symbol GLUE, CIK number 1826457) see the Securities and Exchange Commission (SEC) website.